Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 15/928,702, filed Mar 22, 2018. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,705,070 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug In force · High confidence | Abraxis Bioscience, LLC | In force | High confidence | ||
| US 11,320,416 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug In force · Medium confidence | Abraxis Bioscience, LLC | In force | Medium confidence | ||
| US 12,061,183 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug In force · Medium confidence | Abraxis Bioscience, LLC | In force | Medium confidence | ||
| Application 15/062,048 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug Abandoned Abandoned Mar 26, 2018 | Abraxis Bioscience, LLC | Abandoned | Abandoned Mar 26, 2018 | not computed | |
| Application 15/928,702 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug Abandoned Abandoned Mar 21, 2019 | Abraxis Bioscience, LLC | Abandoned | Abandoned Mar 21, 2019 | not computed | |
| Application 17/701,188 | Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Poorly Water Soluble Drug Abandoned Abandoned Sep 29, 2022 | Abraxis Bioscience, LLC | Abandoned | Abandoned Sep 29, 2022 | not computed |
6 of 6 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Abraxis Bioscience, LLC.
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.